SCHEMBL5793809

SCHEMBL5793809

c1ccc(CN2CC3C(COC4CC(N5CCOCC5)C4)C3C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
HRH3 Q9Y5N1 7/20 0.39
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
RECQL P46063 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
TACR1 P25103 1/20 0.36
FUCA1 P04066 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8192854 0.78 SIGMAR1 (0.50) TSHRHRH3HTTKDM4EALDH1A1
SCHEMBL5809623 0.78 RECQL (0.42) TSHRHRH3ALDH1A1SMN1; SMN2DRD2
SCHEMBL21827417 0.77 MEN1 (0.44) TSHRHRH3ALDH1A1TMEM97SIGMAR1
SCHEMBL21828142 0.77 MEN1 (0.44) TSHRHRH3ALDH1A1TMEM97SIGMAR1
SCHEMBL21141930 0.77 MEN1 (0.44) TSHRHRH3ALDH1A1TMEM97SIGMAR1
SCHEMBL5793619 0.76 LTA4H (0.39) ALDH1A1SMN1; SMN2DRD2DRD4DRD3
SCHEMBL17220125 0.76 BCHE (0.44) ALDH1A1DRD2DRD4DRD3FUCA1
SCHEMBL17220126 0.76 BCHE (0.44) ALDH1A1DRD2DRD4DRD3FUCA1
SCHEMBL5796110 0.73 BCHE (0.38) DRD2DRD3FUCA1
SCHEMBL22399626 0.73 BCHE (0.43) HRH3HTTALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006024955-A1 AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-03-09 WO claimed
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists PFIZER INC 2006-03-02 US claimed
WO-2006024955-A1 AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-03-09 WO disclosed
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists PFIZER INC 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists HRH3, HRH4, HRH2 TSHR 535/4885HRH3 1/4885HTT 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.